We’re delighted that our Managing Director, Sabina Syed, has been featured in Pharmaceutical Market Europe (PME) with a new thought leadership article exploring how the future of healthcare value is changing.
In The outcomes economy: Where next for pharma?, Sabina reflects on key themes emerging from this year’s ISPOR conference and considers how healthcare digitisation, real-world data and evolving payer expectations are reshaping market access.
The article argues that the industry is moving beyond evaluating medicines solely on clinical efficacy, safety and price. Instead, future value frameworks are likely to place increasing emphasis on measurable patient outcomes, affordability and the effectiveness of the wider healthcare delivery ecosystem that supports treatment.
It also explores the opportunities this presents for pharmaceutical companies: from designing trials that better reflect real-world care pathways to developing stronger partnerships with health systems and generating evidence that demonstrates long-term value for patients, payers and society.
If you’re involved in market access, HEOR, pricing, reimbursement or commercial strategy, we’d love to hear your thoughts.
